99 related articles for article (PubMed ID: 12134168)
21. [New methods in insulin treatment].
Neuwirth G
Orv Hetil; 2005 Jan; 146(3):111-6. PubMed ID: 15693442
[TBL] [Abstract][Full Text] [Related]
22. Investigation of drug loading and in vitro release mechanisms of insulin-lauryl sulfate complex loaded PLGA nanoparticles.
Shi K; Cui F; Yamamoto H; Kawashima Y
Pharmazie; 2008 Dec; 63(12):866-71. PubMed ID: 19177901
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms by which moisture generates cocrystals.
Jayasankar A; Good DJ; Rodríguez-Hornedo N
Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
[TBL] [Abstract][Full Text] [Related]
24. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
[TBL] [Abstract][Full Text] [Related]
25. Effects of absorption promoters on insulin absorption through colon-targeted delivery.
Katsuma M; Watanabe S; Kawai H; Takemura S; Sako K
Int J Pharm; 2006 Jan; 307(2):156-62. PubMed ID: 16289574
[TBL] [Abstract][Full Text] [Related]
26. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX
J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718
[TBL] [Abstract][Full Text] [Related]
27. Insulin's 85th anniversary--An enduring medical miracle.
Heller S; Kozlovski P; Kurtzhals P
Diabetes Res Clin Pract; 2007 Nov; 78(2):149-58. PubMed ID: 17482306
[TBL] [Abstract][Full Text] [Related]
28. [Insulin analogues: place of detemir (Levemir)].
Dorchy H; Sternon J
J Pharm Belg; 2006; 61(2):58-62. PubMed ID: 16866083
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
30. Design and evaluation of oral bioadhesive controlled release formulations of miglitol, intended for prolonged inhibition of intestinal alpha-glucosidases and enhancement of plasma glucagon like peptide-1 levels.
Deshpande MC; Venkateswarlu V; Babu RK; Trivedi RK
Int J Pharm; 2009 Oct; 380(1-2):16-24. PubMed ID: 19563873
[TBL] [Abstract][Full Text] [Related]
31. Insulin analogues in the management of diabetes.
Vázquez-Carrera M; Silvestre JS
Methods Find Exp Clin Pharmacol; 2004; 26(6):445-61. PubMed ID: 15349139
[TBL] [Abstract][Full Text] [Related]
32. Novel iron-polysaccharide multilayered microcapsules for controlled insulin release.
Zheng J; Yue X; Dai Z; Wang Y; Liu S; Yan X
Acta Biomater; 2009 Jun; 5(5):1499-507. PubMed ID: 19231303
[TBL] [Abstract][Full Text] [Related]
33. [Insulin polyamino acid complexes--a variable principle in the preparation of sustained-release forms].
Losse G; Raddatz H; Naumann W; Kossowicz J
Pharmazie; 1988 Feb; 43(2):105-9. PubMed ID: 3293085
[TBL] [Abstract][Full Text] [Related]
34. New long-acting insulin available.
Mayo Clin Health Lett; 2001 Sep; 19(9):4. PubMed ID: 11547604
[No Abstract] [Full Text] [Related]
35. A novel protein cross-linking reaction in stressed Neutral Protamine Hagedorn formulations of insulin.
Beavis RC; Kneirman MD; Sharknas D; Heady MA; Frank BH; DeFelippis MR
J Pharm Sci; 1999 Mar; 88(3):331-6. PubMed ID: 10052992
[TBL] [Abstract][Full Text] [Related]
36. Insulin formulation and delivery.
Brange J; Langkjaer L
Pharm Biotechnol; 1997; 10():343-409. PubMed ID: 9160379
[No Abstract] [Full Text] [Related]
37. [Prolonged-release drug formulations for parenteral administration. Part l. Suspensions and oily solutions for injection].
Płaczek M; Jacyna J; Sznitowska M
Pol Merkur Lekarski; 2013 Dec; 35(210):391-6. PubMed ID: 24490472
[TBL] [Abstract][Full Text] [Related]
38. Proceedings: Pharmacodynamics of chemically modified insulins.
Jones RH; Dron DI; Ellis MJ; Sönksen PH
J Endocrinol; 1975 Jun; 65(3):58P. PubMed ID: 1151257
[No Abstract] [Full Text] [Related]
39. Reversible adsorption of soluble hexameric insulin onto the surface of insulin crystals cocrystallized with protamine: an electrostatic interaction.
Dodd SW; Havel HA; Kovach PM; Lakshminarayan C; Redmon MP; Sargeant CM; Sullivan GR; Beals JM
Pharm Res; 1995 Jan; 12(1):60-8. PubMed ID: 7724489
[TBL] [Abstract][Full Text] [Related]
40. Simple Protein Modification Using Zwitterionic Polymer to Mitigate the Bioactivity Loss of Conjugated Insulin.
Xie J; Lu Y; Wang W; Zhu H; Wang Z; Cao Z
Adv Healthc Mater; 2017 Jun; 6(11):. PubMed ID: 28337855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
